TP53 and ovarian cancer: In the present study, we aimed at comparing the state-of-the-art technique co-immunofluorescence (co-IF) with novel assays such as the proximity ligation assay (PLA), co-immunoprecipitation (co-IP), and the p53-Seprion-ELISA (Figure 1) in cancer cell lines and ovarian cancer tissues.